DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Total Expenditure History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Expenditure | ₹6,391 Cr | ₹5,639 Cr | ₹5,398 Cr | ₹5,079 Cr | ₹4,108 Cr |
What is the latest Total Expenditure of DIVIS LABORATORIES ?
Year | Total Expenditure |
---|---|
Mar2025 | ₹6,391 Cr |
Mar2024 | ₹5,639 Cr |
Mar2023 | ₹5,398 Cr |
Mar2022 | ₹5,079 Cr |
Mar2021 | ₹4,108 Cr |
How is Total Expenditure of DIVIS LABORATORIES Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2025 | ₹6,391 Cr | 13.34 | |
Mar2024 | ₹5,639 Cr | 4.46 | |
Mar2023 | ₹5,398 Cr | 6.29 | |
Mar2022 | ₹5,079 Cr | 23.62 | |
Mar2021 | ₹4,108 Cr | - |
Compare Total Expenditure of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹168,831.5 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
MANKIND PHARMA | ₹105,753.0 Cr | 0.8% | 8.4% | 26.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -3.3% |
-7.4% |
34.1% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses